SynthesisClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Comparing Efficacy and Safety of Dual Antiplatelet Therapy versus Intravenous Thrombolytics in Acute Minor Ischemic Stroke: A Systematic Review and Meta-Analysis.
Synthesis in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundAcute minor ischemic stroke (AMIS) frequently results in significant disability despite current treatment options. This meta-analysis evaluated the effectiveness and safety of dual antiplatelet therapy (DAPT) compared to intravenous thrombolytics (IVT) in treating AMIS.MethodsPubMed, Cochrane Central, and ScienceDirect were searched till May 2025. Using a superiority framework, the risk ratios (RRs) along with 95% confidence intervals (CIs) were pooled under a random effects model using the Review Manager version 5.4.1. The quality assessment was done through the Cochrane Risk of Bias (RoB 2.0) and ROBINS-I tools. The primary and secondary outcomes assessed were functional (excellent and favourable) outcomes, symptomatic intracranial hemorrhage (sICH), recurrent ischemic strokes, all-cause mortality, and early neurological deterioration (END). Publication bias was evaluated via the funnel plots and Egger's regression analysis.ResultsSix studies pooling 7,366 AMIS patients were included in the meta-analysis. DAPT significantly reduced the END compared to IVT (RR = 0.50; 95%CI:[0.28, 0.89]; p = 0.02). The functional outcomes, including excellent (RR = 0.97; 95%CI:[0.87, 1.07]; p = 0.52) and favourable (RR = 1.00; 95%CI:[0.97, 1.03]; p = 0.97) functional outcomes, were comparable between DAPT and IVT. Likewise, the safety endpoints including sICH (RR = 0.27; 95%CI:[0.05, 1.38]; p = 0.12), recurrent ischemic strokes (RR = 0.89; 95%CI:[0.59, 1.34]; p = 0.59) and all-cause mortality (RR = 0.51; 95%CI:[0.21, 1.23]; p = 0.13) showed no significant difference between the two groups.ConclusionDAPT is associated with lower END rates than IVT in AMIS management. Both groups showed similar efficacy regarding the functional outcomes. Safety outcomes, including sICH, recurrent stroke, and mortality, also showed no significant difference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.